journal article·2023-05-24

The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression

Fenfen Li, Zhaoxia Cheng, Jingyi Sun, Xiaoyu Cheng, Chen Li, Zhouliang Wu, Feilong Qi, Ying Zhao, Guangjun Nie

Nano Letters· Volume 23· Issue 10
Publisher page

Abstract

Chronic liver injury and continuous wound healing lead to extracellular matrix (ECM) deposition and liver fibrosis. The elevated production of reactive oxygen species (ROS) in the liver leads to the apoptosis of hepatocytes and the activation of hepatic stellate cells (HSCs). In the current study, we describe a combination strategy of sinusoidal perfusion enhancement and apoptosis inhibition enabled by riociguat together with a tailor-designed galactose-PEGylated bilirubin nanomedicine (Sel@GBRNPs). Riociguat enhanced sinusoidal perfusion and decreased the associated ROS accumulation and inflammatory state of the fibrotic liver. Concurrently, hepatocyte-targeting galactose-PEGylated bilirubin scavenged excessive ROS and released encapsulated selonsertib. The released selonsertib inhibited apoptosis signal-regulating kinase 1 (ASK1) phosphorylation to alleviate apoptosis in hepatocytes. The combined effects on ROS and hepatocyte apoptosis attenuated the stimulation of HSC activation and ECM deposition in a mouse model of liver fibrosis. This work provides a novel strategy for liver fibrosis treatment based on sinusoidal perfusion enhancement and apoptosis inhibition.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Liver Disease Diagnosis and Treatment · Organ Transplantation Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China

Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China

College of Chemistry, Zhengzhou University, Zhengzhou 450001, China

GBA Research Innovation Institute for Nanotechnology, Guangzhou 510530, China

Funding

Guangdong Science and Technology Department · Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China · Beijing Nova Program · Chinese Academy of Sciences

References (31)

Show source-provided references
1. 10.1038/s41565-020-00836-610.1038/s41565-020-00836-6 ↗
2. 10.1038/s41575-020-00372-710.1038/s41575-020-00372-7 ↗
3. 10.1002/hep.3180110.1002/hep.31801 ↗
4. 10.1016/j.addr.2021.11388810.1016/j.addr.2021.113888 ↗
5. 10.4254/wjh.v10.i1.110.4254/wjh.v10.i1.1 ↗
6. 10.1038/s41598-017-03389-210.1038/s41598-017-03389-2 ↗
7. 10.1172/JCI7372210.1172/JCI73722 ↗
8. 10.1016/j.jhep.2021.02.01210.1016/j.jhep.2021.02.012 ↗
9. 10.2183/pjab.88.43410.2183/pjab.88.434 ↗
10. 10.1002/hep.2951410.1002/hep.29514 ↗
11. 10.1016/j.jhep.2020.02.02710.1016/j.jhep.2020.02.027 ↗
12. 10.1007/978-3-319-95288-810.1007/978-3-319-95288-8 ↗
13. 10.1038/s41598-019-54663-410.1038/s41598-019-54663-4 ↗
14. 10.1016/j.mehy.2018.11.01410.1016/j.mehy.2018.11.014 ↗
15. 10.3390/cells904092910.3390/cells9040929 ↗
16. 10.3389/fphys.2017.0029110.3389/fphys.2017.00291 ↗
17. 10.1007/s12274-022-5071-210.1007/s12274-022-5071-2 ↗
18. 10.1016/j.redox.2015.08.01510.1016/j.redox.2015.08.015 ↗
19. 10.1007/s00109-020-01878-y10.1007/s00109-020-01878-y ↗
20. 10.1038/s41598-018-27656-y10.1038/s41598-018-27656-y ↗
21. 10.1177/205064062094414010.1177/2050640620944140 ↗
22. 10.1002/anie.20160485810.1002/anie.201604858 ↗
23. 10.1016/j.jconrel.2020.07.01510.1016/j.jconrel.2020.07.015 ↗
24. 10.1038/s41563-019-0462-910.1038/s41563-019-0462-9 ↗
25. 10.1016/j.jconrel.2019.06.02310.1016/j.jconrel.2019.06.023 ↗
26. 10.1002/9780470747919.ch2610.1002/9780470747919.ch26 ↗
27. 10.1053/jhep.2002.3252410.1053/jhep.2002.32524 ↗
28. 10.1016/j.cell.2021.05.00310.1016/j.cell.2021.05.003 ↗
29. 10.1002/cbdv.20200025110.1002/cbdv.202000251 ↗
30. 10.1136/gutjnl-2017-31410710.1136/gutjnl-2017-314107 ↗
31. 10.1007/s12274-020-2833-610.1007/s12274-020-2833-6 ↗